Huihai Pharmaceuticals

The State Administration for Market Regulation (SAMR) has imposed administrative penalties on Grand Pharmaceutical Group Limited (HKG: 0512) and WuHan Huihai Pharmaceuticals Co., Ltd. The two companies were found guilty of reaching and implementing a monopoly agreement and abusing their dominant market position in the sales of active pharmaceutical ingredients…